|
|
||||||||
American Journal of Clinical Nutrition, Vol 44, 973-985, Copyright © 1986 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
MK Horwitt
Data from the long-term projects sponsored by the Food and Nutrition Board to determine the requirements for thiamin, riboflavin, niacin- tryptophan, and vitamin E are utilized to effect an opinion regarding the recommended dietary allowances for these vitamins. Based upon data obtained during these and subsequent research projects, comments on balance studies, changes in tissue lipids, and the requirements for vitamin B-6 are included. The possibility that antioxidants may have an effect on delaying oncogenesis is discussed.
This article has been cited by other articles:
![]() |
S. Hustad, M. C. McKinley, H. McNulty, J. Schneede, J.J. Strain, J. M. Scott, and P. M. Ueland Riboflavin, Flavin Mononucleotide, and Flavin Adenine Dinucleotide in Human Plasma and Erythrocytes at Baseline and after Low-Dose Riboflavin Supplementation Clin. Chem., September 1, 2002; 48(9): 1571 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K Horwitt My valedictory on the differences in biolog-ical potency between RRR-{alpha}-tocopheryl and all-rac-{alpha}-tocopheryl acetate Am. J. Clinical Nutrition, February 1, 1999; 69(2): 341 - 342. [Full Text] [PDF] |
||||
![]() |
T. V. Nattakom, A. Charlton, and D. W. Wilmore Use of Vitamin E and Glutamine in the Successful Treatment of Severe Veno-Occlusive Disease Following Bone Marrow Transplantation Nutr Clin Pract, February 1, 1995; 10(1): 16 - 18. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |